SMTL ID : 6wol.1

Next generation monomeric IgG4 Fc bound to neonatal Fc receptor

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.49 Å
Oligo State
hetero-1-1-1-mer
Ligands
1 x NAG- NAG- BMA- MAN- NAG- MAN- NAG- FUL: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Shan, L. et al., In vivo pharmacokinetic enhancement of monomeric Fc and monovalent bispecific designs through structural guidance. Commun Biol (2021)
Release Date
2021-09-15
Peptides
Immunoglobulin heavy constant gamma 4: A
IgG receptor FcRn large subunit p51: B
Beta-2-microglobulin: C
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
H
B
A
C
B

Immunoglobulin heavy constant gamma 4

IgG receptor FcRn large subunit p51

Beta-2-microglobulin

Related Entries With Identical Sequence

1a1m.1 | 1a1n.1 | 1a1o.1 | 1a6z.1 | 1a6z.2 | 1agb.1 | 1agc.1 | 1agd.1 | 1age.1 | 1agf.1 | 1akj.1 | 1c16.1 | 1c16.2 | 1c16.3 | 1c16.4 | 1c16.5 | 1de4.1 | 1de4.2 | 1e27.1 | 1e28.1 | 1exu.1 | 1hsa.1 | 1hsa.2 | 1hsb.1 | 1m05.1 | 1m05.2 | 1m6o.1 | 1mi5.1 | 1n2r.1 | 1onq.1  more...